Mereo BioPharma Group

NASDAQ: MREO · Real-Time Price · USD
1.74
0.03 (1.75%)
At close: Aug 15, 2025, 3:59 PM
1.74
0.00%
After-hours: Aug 15, 2025, 07:50 PM EDT

Mereo BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-47.19M -43.25M -43.91M -36.91M -38.26M -41.39M -51.34M -53.77M -65M -65.51M -46.98M -36.12M 5.5M 26.42M -25.39M -50.98M -224.7M
Depreciation & Amortization
573.33K 704.17K 793.8K 1.26M 1.5M 1.45M 1.46M 1.29M 1.33M 1.39M 1.55M 1.61M 1.43M 1.32M 1.56M 1.67M 2.59M
Stock-Based Compensation
7.62M 7.39M 7.11M 6.65M 5.37M 4.95M 4.63M 4.37M 5.06M 5.03M 5.16M 5.18M 4.91M 4.51M 3.91M 3.29M 2.64M
Other Working Capital
1.16M n/a 768.73K -306.34K -2.53M -1.81M -2.1M -3.41M -603.25K -162.25K 151.09K 1.64M -1.71M -1.71M -2.02M -2.02M -4.64M
Other Non-Cash Items
1.57M 4.66M 10.32M 4.99M 16.44M 13.28M 9.71M 5.99M -7.45M -9.26M -30.49M -40.09M -35.13M -35M 13.53M 39.03M 184.54M
Deferred Income Tax
n/a n/a 8.77M 8.77M n/a n/a -9.86M -9.86M -2.97M -2.97M -1.88M -1.88M n/a n/a n/a n/a n/a
Change in Working Capital
2.13M 622.17K 3.11M 6.47M -2.8M -925.75K -4.34M -9.21M 840.47K 686.87K 2.14M 4.54M -1.56M -2.94M -3.89M -4.18M -5.16M
Operating Cash Flow
-33.17M -32.83M -25.53M -20.48M -29.31M -30.57M -49.07M -60.52M -67.95M -71.05M -71.33M -67.6M -29.69M -10.51M -15.63M -16.51M -45M
Capital Expenditures
679.22K -382 415.2K -284.02K -699.6K -419K -833.36K -834.29K -431.67K -19.24K -749.46K -1.11M -1.1M -1.09M -381.35K -31.21K -31.21K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 355.03K 355.03K -462.23K
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-998K -1.4M -1.69M -1.28M -1.2M -418.38K -224.34K 516.86K 1.48M 2.05M 2.3M 1.93M 877.1K 231.49K -19.18K -223.06K 2.25M
Investing Cash Flow
-319.4K -699K -991.31K -1.28M -1.7M -1.42M -1.22M -481.41K 972.45K 2.03M 1.55M 818.65K -218.94K -857.97K -491.29K -345.02K 1.76M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
46.57M 46.15M 50.76M 55.9M 9.18M 8.62M 4.32M 40.58K -204.14K 169.09K -347.53K -850.08K 107.66M 161.62M 147.87M 138.55M 93.35M
Financial Cash Flow
46.57M 46.15M 50.76M 55.9M 8.94M 8.37M 3.26M -1.02M -1.22M -849.74K -2.83M -3.33M 105.38M 159.34M 147.87M 138.55M 93.35M
Net Cash Flow
12.91M 12.38M 26.78M 36.98M -16.01M -15.62M -44.34M -81.83M -102.52M -105.89M -105.23M -81.67M 73.25M 144.7M 130.94M 120.07M 48.61M
Free Cash Flow
-33.19M -33.53M -25.81M -20.77M -30.01M -30.99M -49.9M -61.36M -68.38M -71.07M -72.08M -68.71M -30.79M -11.6M -16.01M -16.54M -45.03M